GB9902304D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB9902304D0
GB9902304D0 GBGB9902304.6A GB9902304A GB9902304D0 GB 9902304 D0 GB9902304 D0 GB 9902304D0 GB 9902304 A GB9902304 A GB 9902304A GB 9902304 D0 GB9902304 D0 GB 9902304D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9902304.6A
Other versions
GB2346325A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASSEN INT Ltd
Original Assignee
WASSEN INT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASSEN INT Ltd filed Critical WASSEN INT Ltd
Priority to GB9902304A priority Critical patent/GB2346325A/en
Publication of GB9902304D0 publication Critical patent/GB9902304D0/en
Priority to AU23059/00A priority patent/AU2305900A/en
Priority to GB0118267A priority patent/GB2363571A/en
Priority to PCT/GB2000/000300 priority patent/WO2000045829A1/en
Publication of GB2346325A publication Critical patent/GB2346325A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GB9902304A 1999-02-02 1999-02-02 Formulation comprising a brassica extract or sulforaphane and resveratrol Withdrawn GB2346325A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9902304A GB2346325A (en) 1999-02-02 1999-02-02 Formulation comprising a brassica extract or sulforaphane and resveratrol
AU23059/00A AU2305900A (en) 1999-02-02 2000-02-02 Brassica extracts or sulforaphane in combination with resveratrol as antitumor agents
GB0118267A GB2363571A (en) 1999-02-02 2000-02-02 Brassica extracts or sulforaphane in combination with reseratol as antitumor agents
PCT/GB2000/000300 WO2000045829A1 (en) 1999-02-02 2000-02-02 Brassica extracts or sulforaphane in combination with resveratrol as antitumor agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9902304A GB2346325A (en) 1999-02-02 1999-02-02 Formulation comprising a brassica extract or sulforaphane and resveratrol

Publications (2)

Publication Number Publication Date
GB9902304D0 true GB9902304D0 (en) 1999-03-24
GB2346325A GB2346325A (en) 2000-08-09

Family

ID=10846974

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9902304A Withdrawn GB2346325A (en) 1999-02-02 1999-02-02 Formulation comprising a brassica extract or sulforaphane and resveratrol
GB0118267A Withdrawn GB2363571A (en) 1999-02-02 2000-02-02 Brassica extracts or sulforaphane in combination with reseratol as antitumor agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0118267A Withdrawn GB2363571A (en) 1999-02-02 2000-02-02 Brassica extracts or sulforaphane in combination with reseratol as antitumor agents

Country Status (3)

Country Link
AU (1) AU2305900A (en)
GB (2) GB2346325A (en)
WO (1) WO2000045829A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2094901A (en) * 1999-12-16 2001-06-25 Johnson & Johnson Consumer Companies, Inc. Compositions containing a retinoid and a stilbene for skin care
US7939115B2 (en) 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US6989161B2 (en) 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
US7416749B2 (en) 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
ATE361746T1 (en) * 2002-03-06 2007-06-15 Medical Res And Education Trus BOTANICAL EXTRACT WITH ANTI-CANCER ACTIVITY CONTAINING ISOLIQUIRITIGENIN
CN1723017A (en) 2002-08-05 2006-01-18 伟克沃公司 Methods and compositions to treat conditions associated with neovascularization
HU0800012D0 (en) * 2008-01-10 2008-03-28 Geiszt Miklos Dr Novel use and methods for the treatment and prevention of ulcerative colitis
GB0811992D0 (en) * 2008-07-01 2008-08-06 Mithen Richard Treatment
EP2686021B1 (en) * 2011-03-14 2018-08-15 NSE Products, Inc. Oral formulations for promoting cellular purification
EP2679225A1 (en) * 2012-06-26 2014-01-01 Universitätsklinikum Freiburg Pharmaceutical compound with synergistic effect of direct catalase inhibitors and modulators for NO metabolism which lead to catalase destruction or extracellular superoxide anion production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
US5725895B1 (en) * 1995-09-15 2000-10-10 Hopkins J School Of Medicine Method of preparing food product from cruciferous seeds
US5686108A (en) * 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
US6008260A (en) * 1998-01-09 1999-12-28 Pharmascience Cancer chemopreventative composition and method

Also Published As

Publication number Publication date
WO2000045829A1 (en) 2000-08-10
GB0118267D0 (en) 2001-09-19
GB2363571A8 (en) 2002-01-17
AU2305900A (en) 2000-08-25
GB2363571A (en) 2002-01-02
GB2346325A (en) 2000-08-09

Similar Documents

Publication Publication Date Title
HUP0201489A3 (en) New formulation
GB2359254B (en) Formulation
EP1156812A4 (en) Multiparticulate formulation
EG24226A (en) Formulation
GB0000891D0 (en) Formulation
IL145995A0 (en) Use
GB9913536D0 (en) Use
GB9905898D0 (en) Controlled-dose formulation
GB9902304D0 (en) Formulation
GB9927614D0 (en) Sterliant formulation
GB9914798D0 (en) Ensure
AU141428S (en) Turnpiece
GB9919971D0 (en) Use
GB9902236D0 (en) Formulation
AU140373S (en) Bumbag
GB9908776D0 (en) Formulation
GB9917952D0 (en) Formulation
GB9902089D0 (en) Formulation
GB9923538D0 (en) Formulation
GB9915584D0 (en) Formulation
GB9919060D0 (en) Combination formulation
GB9910118D0 (en) Formulations
EG22401A (en) Set 3c1-strong
GB9921193D0 (en) Disinfectant formulation
GB9823645D0 (en) Formulation

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)